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Published by Elsevier Inc.CORRESPONDENCELetters to the EditorThe Challenge of Obesity
Can We Look to the Moon
Instead of the Finger?
The multiple challenges of obesity encompass in a simple paradigm
what is wrong not only in nutrition but also in the strategies and
medical interventions in our society that are aimed at lifestyle
change management. This is a “hot” point, which also includes
strategies for prescribing healthier and better quality food (1). We
also need to enhance more active physical exercise, considering that
technology is making life more effortless, while making it more
stressful (2). Last but not least, we need to observe with a more
open mind the complexity of the problem, because we see only the
pale reﬂection of the light of a still far-off moon.
On the same date as Dr. DeMaria’s (3) editorial, another valu-
able review was published elsewhere (4): “Myths, Presumptions,
and Facts About Obesity.” However, those investigators skipped
several core points. We think that in this ﬁeld, we can move with
greater decisiveness from myths to ideas, going beyond common
concepts and dogmas on obesity. In obesity, 2 concepts and con-
cealed dogmas are critical, being presumptions that even go against
established facts.
First, obesity is considered invariably ominous for health, trusting
that limits, deﬁned by epidemiology, are the gold standards, alone, for
healthy weight, obesity, and risks for diseases. Nonetheless, under
several conditions, being overweight appears “protective” (the obesity
paradox), at least against renal and heart failure (5). This issue is
strongly debated (6), but we lack still a good deﬁnition of the healthy
overweight, if any.
Second, obesity is regarded as an exclusive consequence of an
imbalance between food intake and physical exercise, modulated by
endocrine and genetic factors. Economists and, obviously, epide-
miologists cite environment, but they omit the evidence that envi-
ronmental infections, and notably adipogenic adenovirus infections
in humans, are associated with obesity, being causative factors of
obesity and consequent disease in animals (7–9).
In both cases, there is still limited epidemiological information,
even based on extensive human investigations in different parts of
the world.
As Dr. DeMaria (3) states, the time has come for the medical
community to become more organized and proactive in engaging
the public and the food industry to emphasize the health hazards
associated with obesity: we must seek solutions to the problem
without bias and explore these and other neglected ﬁelds, such as
the quality of nutritional proﬁles (1), in which considerable
evidence is already available.*Guglielmo M. Trovato, MD
Daniela Catalano, MD
Francesca M. Trovato, MD*University of Catania







1. DeMaria AN. “Eat food, not very much, mostly plants.” J Am Coll
Cardiol 2010;55:2288–9.
2. DeMaria AN. The tyranny of the cell phone. J Am Coll Cardiol 2012;
59:2388–9.
3. DeMaria AN. The multiple challenges of obesity. J Am Coll Cardiol
2013;61:784–6.
4. Casazza K, Fontaine KR, Astrup A, et al. Myths, presumptions, and
facts about obesity. N Engl J Med 2013;368:446–54.
5. Romero-Corral A, Montori VM, Somers VK, et al. Association of
bodyweight with total mortality and with cardiovascular events in
coronary artery disease: a systematic review of cohort studies. Lancet
2006;368:666–78.
6. Lavie CJ, Milani RV, Ventura HO. Impact of obesity on outcomes in
myocardial infarction combating the “obesity paradox.” J Am Coll
Cardiol 2011;58:2651–3.
7. Atkinson RL, Dhurandhar NV, Allison DB, et al. Human adenovirus-
36 is associated with increased body weight and paradoxical reduction of
serum lipids. Int J Obes (Lond) 2005;29:281–6.
8. Atkinson RL. Human adenovirus-36 and childhood obesity. Int J
Pediatr Obes 2011;6 Suppl:2–6.
9. Trovato GM, Castro A, Tonzuso A, et al. Human obesity relationship
with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009;33:
1402–9.Types of Sleep Apnea in
Patients With Heart Failure
A Spectrum of Disease Severity
or Separate Entities
We read the recently published report by Kasai et al. (1) with keen
interest. The investigators performed a study comparing the appli-
cation of lower body positive airway pressure and its effects on the
neck circumference and partial pressure of carbon dioxide in patients
with heart failure and sleep apnea. These researchers demonstrated
that in all patients with sleep apnea, lower body positive airway
pressure led to a reduction in leg volume and to an increase in neck
circumference. Interestingly, despite such rostral ﬂuid shift, patients
with central sleep apnea (CSA) had a decrease in transpharyngeal
resistance, increased minute ventilation and reduced partial pressure
of carbon dioxide compared with patients with obstructive sleep
apnea, who had opposite ﬁndings.We want to sincerely congratulate
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some questions that need to be addressed in future research.
The investigators speculated that pulmonary congestion (although
they did not monitor this parameter in the study) and subsequent
stimulation of pulmonary irritant receptors might explain why
patients with CSA had an increase in minute ventilation and reduced
partial pressure of carbon dioxide via increased respiratory drive.
Therefore, the question that arises is why more ﬂuid goes to the
lungs in patients with CSA compared with patients with obstructive
sleep apnea (presumed to be the case because of opposite ﬁndings in
the study): is it related to a greater ﬂuid volume in cases of more
advanced heart failure? It is well known that the prevalence of CSA
increases with a greater severity of heart failure (2); thus, the presence
of CSA may simply reﬂect the degree of cardiac dysfunction.
Therefore, patterns of sleep apnea may change over time on the basis
of the status of cardiac performance.
Alternatively, other mechanisms yet to be elucidated may be
responsible for greater pulmonary congestion in patients with CSA.
Fluid overload and pulmonary congestion may explain why patients
with renal disease have a greater prevalence of CSA compared with
the general population (3). Therefore, it is important to study
whether pulmonary congestion and stimulation of pulmonary irri-
tant receptors will explain the different response to rostral ﬂuid shift
in patients with CSA and obstructive sleep apnea (4).*Aibek E. Mirrakhimov, MD
Erkin M. Mirrakhimov, MD, PhD
*Saint Joseph Hospital
Department of Internal Medicine




1. Kasai T, Motwani SS, Yumino D, et al. Contrasting effects of lower
body positive pressure on upper airways resistance and partial pressure of
carbon dioxide in men with heart failure and obstructive or central sleep
apnea. J Am Coll Cardiol 2013;61:1157–66.
2. Oldenburg O. Cheyne-stokes respiration in chronic heart failure. Treat-
ment with adaptive servoventilation therapy. Circ J 2012;76:2305–17.
3. Tada T, Kusano KF, Ogawa A, et al. The predictors of central and
obstructive sleep apnoea in haemodialysis patients. Nephrol Dial
Transplant 2007;22:1190–7.
4. Mirrakhimov AE. Supine ﬂuid redistribution: should we consider this
as an important risk factor for obstructive sleep apnea? Sleep Breath 2013;
17:511–23.ReplyTypes of Sleep Apnea in Patients With
Heart Failure: A Spectrum of Disease
Severity or Separate Entities
Drs. Mirrakhimov and Mirrakhimov ask why more ﬂuid would be
redistributed in the lungs by application of lower body positive
pressure (LBPP) in patients with heart failure with central sleepapnea (CSA) than in those with obstructive sleep apnea, thus
stimulating pulmonary vagal irritant receptors that provoke
hyperventilation. They ask further whether this might be due to
a greater degree of volume overload in those with CSA.
In fact, we stated in the report that such differing responses may be
related to differing cardiac loading conditions (1). For example,
previous studies have shown that nonchemical pulmonary irritant
receptor stimulation by pulmonary congestion provokes hypocapnia
(2), that in patients with heart failure, partial pressure of carbon
dioxide is inversely proportional to left ventricular ﬁlling pressure (3),
and that reducing left ventricular ﬁlling pressure was associated with
attenuation of CSA (4). In our study, we observed that compared
with obstructive-dominant patients, central-dominant patients had
a much greater degree of mitral regurgitation, as well as higher right
ventricular systolic pressure and levels of N-terminal pro–B-type
natriuretic peptide, all of which are indicative of greater left
ventricular ﬁlling pressures and suggestive of greater pulmonary
congestion (5). Accordingly, for a similar ﬂuid shift from the legs into
the heart in response to LBPP, pulmonary congestion with stimu-
lation of vagal irritant receptors, a consequent increase in ventilation,
and a decrease in partial pressure of carbon dioxide would more likely
occur in patients with higher than in those with lower left ventricular
ﬁlling pressures. The signiﬁcant relationships between N-terminal
pro–B-type natriuretic peptide levels and indicators of increased
respiratory drive in response to LBPP further support this concept.
Drs. Mirrakhimov and Mirrakhimov also speculate that the type
of sleep apnea could change over time in response to alterations in
cardiac function. We agree, and in fact cited our previous work, in
which we demonstrated that the predominant type of sleep apnea
could shift from obstructive sleep apnea to CSA over time, in
association with a deterioration in cardiac function and a decrease
in partial pressure of carbon dioxide, and vice versa (6,7). We also
agree that ﬂuid overload and pulmonary congestion may explain the
higher prevalence of CSA in the renal failure population than in the
general population.
Finally, we concur with Drs. Mirrakhimov and Mirrakhimov
that future studies would ideally directly quantify lung water or left
ventricular ﬁlling pressure in response to interventions such as
LBPP and take us a step closer to deﬁning the mechanism for the
hyperventilatory response to LBPP observed in our patients with
heart failure with predominantly CSA.
*T. Douglas Bradley, MD
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